Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 293 insiders at 194 companies
- $6.3B sold by 282 insiders outside a trading plan
- $3.3B sold by 627 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, Isolde O'Hanlon Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Larry C Glasscock DirectorSPGSimon Property Group, Inc.Buy$74K 367 shares at $202.78 +0.8% to stakeTraded Sep 30 Filed Oct 1
-
Martin J Cicco DirectorSPGSimon Property Group, Inc.Buy$3,042 15 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Glyn Aeppel DirectorSPGSimon Property Group, Inc.Buy$45K 222 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Michael J Happe DirectorFULH. B. Fuller CompanyBuy$99K 2,000 shares at $49.63 +149% to stakeTraded Sep 29 Filed Oct 1
-
Celine Christine Martin DirectorFULH. B. Fuller CompanyBuy$23K 465 shares at $49.50 New stakeTraded Sep 30 Filed Oct 1
-
Milton C Ault III Chair · +1 joint filerGPUSHyperscale Data, Inc.Buy$5.1M 10.3M shares at $0.4900Traded Sep 29–30 Filed Oct 1
-
John W. Higuchi DirectorLPCNLipocine Inc.Buy$27K 12,561 shares at $2.16 +6.2% to stakeTraded Sep 28 Filed Sep 30
-
Paul Seid DirectorINLXIntellinetics, Inc.Buy$948 184 shares at $5.15 +0.1% to stakeTraded Sep 28–30 Filed Sep 30
-
Joshua Horowitz DirectorKWYKingsway CorporationBuy$33K 3,575 shares at $9.26 +0.9% to stakeTraded Sep 28–30 Filed Sep 30
-
Robert Thomas Devincenzi DirectorUTIUniversal Technical Institute IncBuy$20K 1,000 shares at $19.68 +0.7% to stakeTraded Sep 28 Filed Sep 30
-
Leonard M Tannenbaum DirectorAFCGAdvanced Flower Capital Inc.Buy$344K 95,397 shares at $3.61 +1.4% to stakeTraded Sep 28–30 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$63.4M 715,592 shares at $88.59 +3.7% to stakeTraded Sep 28–29 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$35M 418,323 shares at $83.58 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$58.6M 807,840 shares at $72.57 +4.4% to stakeTraded Sep 28 Filed Sep 30
-
Stanley Frankel DirectorDTILPrecision BioSciences, Inc.Buy$6,000 1,000 shares at $6.00 +2.5% to stakeTraded Sep 28 Filed Sep 30
-
James L Robo DirectorKBDCKayne Anderson BDC, Inc.Buy$1.9M 146,755 shares at $13.03 +24% to stakeTraded Sep 28 Filed Sep 30
-
Ronald Todd Plott DirectorPHIOPhio Pharmaceuticals Corp.Buy$10K 10,000 shares at $1.04 +31% to stakeTraded Sep 28–29 Filed Sep 30
-
Thomas W Handley DirectorFULH. B. Fuller CompanyBuy$99K 2,000 shares at $49.41 New stakeTraded Sep 28 Filed Sep 30
-
Daniel L Florness DirectorFULH. B. Fuller CompanyBuy$100K 2,030 shares at $49.34 +150% to stakeTraded Sep 28 Filed Sep 30
-
Trangsrud Teresa J Rasmussen DirectorFULH. B. Fuller CompanyBuy$100K 2,042 shares at $48.96 +102% to stakeTraded Sep 28 Filed Sep 30
-
Charles T Lauber DirectorFULH. B. Fuller CompanyBuy$100K 2,005 shares at $49.87 +148% to stakeTraded Sep 29 Filed Sep 30
-
Srilata Zaheer DirectorFULH. B. Fuller CompanyBuy$100K 2,040 shares at $49.08 +152% to stakeTraded Sep 28–29 Filed Sep 30
-
Yair Nechmad ChairNYAXNayax Ltd.Buy$2.1M 46,935 shares at $44.90 +0.6% to stakeTraded Sep 28–29 Filed Sep 30
-
Robert John Andrew Ryan DirectorASPIASP Isotopes Inc.Buy$22K 8,000 shares at $2.70 +1.2% to stakeTraded Sep 28 Filed Sep 30
-
Howard S Jonas DirectorZDGEZedge, Inc.Buy— 2,218,430 shares New stakeTraded Sep 25 Filed Sep 29
-
Ivan Brockman DirectorVRAVera Bradley, Inc.Buy$10K 2,500 shares at $4.00 New stakeTraded Sep 25 Filed Sep 29
-
Lori Wittman DirectorAHRTAH Realty Trust, Inc.Buy$18K 3,000 shares at $5.95 New stakeTraded Sep 28 Filed Sep 29
-
William L Burnham DirectorHGBLHeritage Global Inc.Buy$399K 300,000 shares at $1.33 New stakeTraded Sep 25 Filed Sep 29
-
Randy S. Bimes DirectorQNBCQNB Corp.Buy$10K 221 shares at $45.30 +0.1% to stakeTraded Sep 25 Filed Sep 29
-
Daniel J Leonard DirectorOVLYOak Valley Bancorp (CA)Buy$4,254 125 shares at $34.03 +0.2% to stakeTraded Sep 28 Filed Sep 29
-
Paul Howard Sutherland DirectorGAIAGaia, Inc.Buy$2,610 2,000 shares at $1.31 +0.4% to stakeTraded Sep 25 Filed Sep 29
-
Melinda Brown DirectorDTILPrecision BioSciences, Inc.Buy$7,116 1,135 shares at $6.27 +2.6% to stakeTraded Sep 25 Filed Sep 29
-
Geno J Germano DirectorDTILPrecision BioSciences, Inc.Buy$16K 2,609 shares at $6.28 +5.8% to stakeTraded Sep 25 Filed Sep 29
-
John Adam Robertson ChairCBKCommercial Bancgroup, Inc.Buy$2,288 70 shares at $32.69 +0.2% to stakeTraded Sep 16 Filed Sep 28
-
D Jonathan Merriman DirectorPODCPodcastOne, Inc.Buy$24K 11,000 shares at $2.21 +3% to stakeTraded Sep 24 Filed Sep 28
-
Michael Fierman DirectorAOMRAngel Oak Mortgage REIT, Inc.Buy$291K 38,726 shares at $7.50 +58% to stakeTraded Sep 25 Filed Sep 28
-
Anthony Puntillo DirectorFNWDFinward BancorpBuy$234 5 shares at $43.46 +0.2% to stakeTraded Sep 25 Filed Sep 28
-
John Martin Schaible ChairATCHAtlasClear Holdings, Inc.Buy$20K 100,000 shares at $0.2000 +10% to stakeTraded Sep 24–25 Filed Sep 28
-
Steven J. Carlson DirectorATCHAtlasClear Holdings, Inc.Buy$2,945 15,000 shares at $0.2000 New stakeTraded Sep 24–25 Filed Sep 28
-
Thomas Jon Hammond DirectorATCHAtlasClear Holdings, Inc.Buy$100K 500,000 shares at $0.2000 +70822% to stakeTraded Sep 24 Filed Sep 28
-
Leonard M Tannenbaum DirectorAFCGAdvanced Flower Capital Inc.Buy$88K 25,228 shares at $3.50 +0.4% to stakeTraded Sep 24–25 Filed Sep 28
-
William R Shepard DirectorCMECME Group Inc.Buy$79K 293 shares at $268.76 +0.1% to stakeTraded Sep 25 Filed Sep 28
-
Paul Seid DirectorINLXIntellinetics, Inc.Buy$5,603 1,088 shares at $5.15 +0.6% to stakeTraded Sep 24–25 Filed Sep 28
-
Arnold M Baskies DirectorANIXAnixa Biosciences, Inc.Buy$14K 5,000 shares at $2.76 +3.7% to stakeTraded Sep 24 Filed Sep 28
-
Milton C Ault III Chair · +1 joint filerGPUSHyperscale Data, Inc.Buy$117K 689,600 shares at $0.1700Traded Sep 24–25 Filed Sep 28
-
Lozano Rogelio Zambrano DirectorCXCemex S.A.B. de C.V.Buy$6.9M 400,800 shares at $17.28 +4.2% to stakeTraded Sep 25 Filed Sep 25
-
Jack A. Markell DirectorRSIRush Street Interactive, Inc.Buy$29K 1,500 shares at $19.35 +8.6% to stakeTraded Sep 25 Filed Sep 25
-
William Edward Mitchell DirectorUMHUMH Properties, Inc.Buy$20K 1,300 shares at $15.30 +3.7% to stakeTraded Sep 25 Filed Sep 25
-
Sam Levinson DirectorCLPRClipper Realty Inc.Buy$77K 22,923 shares at $3.38 +5.9% to stakeTraded Sep 23–24 Filed Sep 25
-
Patricia A Bradford DirectorPHIOPhio Pharmaceuticals Corp.Buy$6,583 6,500 shares at $1.01 +11% to stakeTraded Sep 24 Filed Sep 25
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.